Dr Anne Beal

Dr Anne Beal is a declared insider of GSK plc, with filings sourced from RNS (LSE). Between 20 June 2023 and 10 July 2026, the trades on record add up to 30 filings.

Purchases make up the whole of the open-market record (15 purchases, €228k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 15 share grants. So far in 2026, the count stands at 3 purchases and no sales.

In size, the median ticket on the buying side is €11k. Of 13 purchases, 13 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 17 July 2026 with a share grant (€2,164) in GSK plc. The clock since the last published purchase (24 June 2026) now reads 119 days. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for notifying a trade is three business days (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.